These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20124285)

  • 1. Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
    Nelson GW; Freedman BI; Bowden DW; Langefeld CD; An P; Hicks PJ; Bostrom MA; Johnson RC; Kopp JB; Winkler CA
    Hum Mol Genet; 2010 May; 19(9):1805-15. PubMed ID: 20124285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
    Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
    Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
    Kopp JB; Smith MW; Nelson GW; Johnson RC; Freedman BI; Bowden DW; Oleksyk T; McKenzie LM; Kajiyama H; Ahuja TS; Berns JS; Briggs W; Cho ME; Dart RA; Kimmel PL; Korbet SM; Michel DM; Mokrzycki MH; Schelling JR; Simon E; Trachtman H; Vlahov D; Winkler CA
    Nat Genet; 2008 Oct; 40(10):1175-84. PubMed ID: 18794856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
    Papeta N; Kiryluk K; Patel A; Sterken R; Kacak N; Snyder HJ; Imus PH; Mhatre AN; Lawani AK; Julian BA; Wyatt RJ; Novak J; Wyatt CM; Ross MJ; Winston JA; Klotman ME; Cohen DJ; Appel GB; D'Agati VD; Klotman PE; Gharavi AG
    J Am Soc Nephrol; 2011 Nov; 22(11):1991-6. PubMed ID: 21997397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.
    Freedman BI; Hicks PJ; Bostrom MA; Comeau ME; Divers J; Bleyer AJ; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
    Nephrol Dial Transplant; 2009 Nov; 24(11):3366-71. PubMed ID: 19567477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
    Behar DM; Rosset S; Tzur S; Selig S; Yudkovsky G; Bercovici S; Kopp JB; Winkler CA; Nelson GW; Wasser WG; Skorecki K
    Hum Mol Genet; 2010 May; 19(9):1816-27. PubMed ID: 20144966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.
    Freedman BI; Hicks PJ; Bostrom MA; Cunningham ME; Liu Y; Divers J; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
    Kidney Int; 2009 Apr; 75(7):736-45. PubMed ID: 19177153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report.
    Reeves-Daniel AM; Iskandar SS; Bowden DW; Bostrom MA; Hicks PJ; Comeau ME; Langefeld CD; Freedman BI
    Am J Kidney Dis; 2010 May; 55(5):e21-4. PubMed ID: 20116156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.
    Cooke JN; Bostrom MA; Hicks PJ; Ng MC; Hellwege JN; Comeau ME; Divers J; Langefeld CD; Freedman BI; Bowden DW
    Nephrol Dial Transplant; 2012 Apr; 27(4):1505-11. PubMed ID: 21968013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene.
    Núñez M; Saran AM; Freedman BI
    Adv Chronic Kidney Dis; 2010 Jan; 17(1):44-51. PubMed ID: 20005488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
    Freedman BI; Langefeld CD; Lu L; Divers J; Comeau ME; Kopp JB; Winkler CA; Nelson GW; Johnson RC; Palmer ND; Hicks PJ; Bostrom MA; Cooke JN; McDonough CW; Bowden DW
    PLoS Genet; 2011 Jun; 7(6):e1002150. PubMed ID: 21698141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study.
    Freedman BI; Kopp JB; Winkler CA; Nelson GW; Rao DC; Eckfeldt JH; Leppert MF; Hicks PJ; Divers J; Langefeld CD; Hunt SC
    Am J Nephrol; 2009; 29(6):626-32. PubMed ID: 19153477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?
    Kopp JB; Winkler CA; Nelson GW
    Semin Nephrol; 2010 Jul; 30(4):409-17. PubMed ID: 20807613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
    Genovese G; Friedman DJ; Ross MD; Lecordier L; Uzureau P; Freedman BI; Bowden DW; Langefeld CD; Oleksyk TK; Uscinski Knob AL; Bernhardy AJ; Hicks PJ; Nelson GW; Vanhollebeke B; Winkler CA; Kopp JB; Pays E; Pollak MR
    Science; 2010 Aug; 329(5993):841-5. PubMed ID: 20647424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
    Kao WH; Klag MJ; Meoni LA; Reich D; Berthier-Schaad Y; Li M; Coresh J; Patterson N; Tandon A; Powe NR; Fink NE; Sadler JH; Weir MR; Abboud HE; Adler SG; Divers J; Iyengar SK; Freedman BI; Kimmel PL; Knowler WC; Kohn OF; Kramp K; Leehey DJ; Nicholas SB; Pahl MV; Schelling JR; Sedor JR; Thornley-Brown D; Winkler CA; Smith MW; Parekh RS;
    Nat Genet; 2008 Oct; 40(10):1185-92. PubMed ID: 18794854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants.
    Gopalakrishnan I; Iskandar SS; Daeihagh P; Divers J; Langefeld CD; Bowden DW; Hicks PJ; Rocco MV; Freedman BI
    Hum Pathol; 2011 Feb; 42(2):291-4. PubMed ID: 21074826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9.
    Genovese G; Tonna SJ; Knob AU; Appel GB; Katz A; Bernhardy AJ; Needham AW; Lazarus R; Pollak MR
    Kidney Int; 2010 Oct; 78(7):698-704. PubMed ID: 20668430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans.
    Freedman BI; Edberg JC; Comeau ME; Murea M; Bowden DW; Divers J; Alarcón GS; Brown EE; McGwin G; Kopp JB; Winkler CA; Nelson GW; Illei G; Petri M; Ramsey-Goldman R; Reveille JD; Vilá LM; Langefeld CD; Kimberly RP;
    Am J Nephrol; 2010; 32(1):66-72. PubMed ID: 20523037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variation.
    Winkler CA; Nelson G; Oleksyk TK; Nava MB; Kopp JB
    Semin Nephrol; 2010 Mar; 30(2):111-25. PubMed ID: 20347641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.